Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Final Height in Children with Growth Hormone Deficiency

Final Height in Children with Growth Hormone Deficiency Forty-six patients (28 boys, 18 girls) were treated with growth hormone (GH) for short stature. Twenty-eight patients had total growth hormone deficiency (GHD), 12 partial GHD and 6 patients had short stature without GHD. Brain tumours were the cause of GHD in 8 patients and multiple pituitary hormone deficiency was present in 9 children. All patients received GH with subcutaneous injections only, 6-7 times/week. Mean final height for all patients was -1.11 SDS and was similar in boys ( 1.09 SDS) and girls (-1.13 SDS). Target height SDS was -0.80 SDS in 42 patients, comparing favourably with a final height SDS of-1.05. Similar results were obtained in all patient sub-groups. Height velocity during the last year of therapy was between 2.1 and 9.9 cm/ year in 34 patients and below 2 cm in 12 patients. As further growth is to be expected, target height will probably be reached by most patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hormone Research in Paediatrics Karger

Final Height in Children with Growth Hormone Deficiency

Loading next page...
 
/lp/karger/final-height-in-children-with-growth-hormone-deficiency-M5bxKx8Akw

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Karger
Copyright
© 1995 S. Karger AG, Basel
ISSN
1663-2818
eISSN
1663-2826
DOI
10.1159/000184256
Publisher site
See Article on Publisher Site

Abstract

Forty-six patients (28 boys, 18 girls) were treated with growth hormone (GH) for short stature. Twenty-eight patients had total growth hormone deficiency (GHD), 12 partial GHD and 6 patients had short stature without GHD. Brain tumours were the cause of GHD in 8 patients and multiple pituitary hormone deficiency was present in 9 children. All patients received GH with subcutaneous injections only, 6-7 times/week. Mean final height for all patients was -1.11 SDS and was similar in boys ( 1.09 SDS) and girls (-1.13 SDS). Target height SDS was -0.80 SDS in 42 patients, comparing favourably with a final height SDS of-1.05. Similar results were obtained in all patient sub-groups. Height velocity during the last year of therapy was between 2.1 and 9.9 cm/ year in 34 patients and below 2 cm in 12 patients. As further growth is to be expected, target height will probably be reached by most patients.

Journal

Hormone Research in PaediatricsKarger

Published: Jan 1, 1995

Keywords: Complete growth hormone deficiency; Partial growth hormone deficiency; Short stature without growth hormone deficiency; Subcutaneous injection of growth hormone; Final height; Target height

There are no references for this article.